Oncobiologics, Inc. (ONS): Stock Offering News

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Key Facts Surrounding This News Item


  • ONS had returned 0.00% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About Oncobiologics, Inc. (ONS)


Oncobiologics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology. The company was founded in 2010 and is based in Cranbury, New Jersey. View our full ONS ticker page with ratings, news, and more.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Top Stories on StockNews.com

: ACB | Aurora Cannabis Inc. Common Shares News, Ratings, and Charts

Marijuana Stocks Weekly Recap

This week in the cannabis sector, we saw news out of Aurora Cannabis (ACB), Innovative Industrial Properties (IIPR), and GW Pharmaceuticals (GWPH)
NASDAQ: AAPL | Apple Inc. News, Ratings, and Charts

3 Must Have Tech Stocks for the Second Half of 2020

Technology stocks like Apple (AAPL), Microsoft (MSFT), and Advanced Micro Devices (AMD) are performing well as society goes digital.
NASDAQ: AMZN | Amazon.com, Inc. News, Ratings, and Charts

5 Cloud Computing Stocks that are Expected to Outperform

Businesses are shifting a greater portion of their operations to the cloud, presenting an opportunity to cloud service providers such as Amazon (AMZN), Alphabet (GOOGL), Adobe (ADBE), Salesforce (CRM), and Splunk (SPLK).
: ZM | Zoom Video Communications, Inc. -  News, Ratings, and Charts

3 Work From Home Stocks for the Second Half of 2020

The world is shifting as professionals increasingly working from home. The demand for services from companies such as Zoom (ZM), Akamai (AKAM) and Dropbox (DBX) is expected to rise over the second half of 2020.
NYSE: DHI | D.R. Horton, Inc.  News, Ratings, and Charts

3 Homebuilders for the Second Half of 2020

With the Fed pushing mortgage rates to record-lows and a housing shortage. D.R. Horton (DHI), Lennar (LEN), and LGI Homes (LGIH) are setting up for second-half outperformance.

Read More Stories


More Oncobiologics, Inc. (ONS) News View All

Event/DateSymbolNews DetailStart PriceEnd PriceChangePOWR Rating
Loading, please wait...
View All ONS News